| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 2 133-141, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
K Swisshelm, K Ryan, X Lee, HC Tsou, M Peacocke and R Sager
Division of Cancer Genetics, Dana-Farber Cancer Institute, Boston, Massachusetts.
Retinoids are important cellular, dietary factors that regulate differentiation and cellular growth. They serve as ligands for specific nuclear receptors, the retinoic acid receptors (RARs). Ligand-activated receptors regulate gene transcription through target retinoic acid-responsive elements (RAREs) found in promoter regions. We have investigated the expression of retinoic acid receptor genes (alpha, beta, gamma) and retinoid X receptor beta in normal, senescing, and tumorigenic human mammary epithelial cells. We find that most tumor cells show a loss of RAR-beta expression, but that RAR-alpha and -gamma as well as retinoid X receptor beta are variably expressed in both normal and tumor cells. RAR-beta gene expression is induced both by retinoic acid and by fenretinide in normal cells, but tumor cells fail to respond to either. In contrast, RAR-beta expression increases with serial passage in senescing cells. Paradoxically, both normal and tumor cells can trans-activate an exogenous beta-RARE, as demonstrated by reporter gene assays. Oligonucleotide mobility shift assays with the beta-RARE show a single discrete complex in normal cells, whereas tumor cells exhibit a heterogeneous set of larger complexes, which indicates that tumor cells utilize a different array of factors within the beta-RARE. Reporter gene assays with extended promoter regions indicate the presence of negative regulatory elements and/or factor binding sites that reside between -1500 and the RARE located at -59, and that the promoter is down-regulated in MCF-7 tumor cells. Our findings reveal a dichotomy: RAR-beta transcription is down-regulated in tumor cells compared with normal human mammary epithelial cells, and up-regulated in senescence.
This article has been cited by other articles:
![]() |
H. Chen, H. Zhang, J. Lee, X. Liang, X. Wu, T. Zhu, P.-k. Lo, X. Zhang, and S. Sukumar HOXA5 Acts Directly Downstream of Retinoic Acid Receptor {beta} and Contributes to Retinoic Acid Induced Apoptosis and Growth Inhibition Cancer Res., September 1, 2007; 67(17): 8007 - 8013. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu and L. J. Gudas Disruption of the Lecithin:Retinol Acyltransferase Gene Makes Mice More Susceptible to Vitamin A Deficiency J. Biol. Chem., December 2, 2005; 280(48): 40226 - 40234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D.-C. Arce, U. Soto, J. van Riggelen, E. Schwarz, H. z. Hausen, and F. Rosl Ectopic Expression of Nonliganded Retinoic Acid Receptor {beta} Abrogates AP-1 Activity by Selective Degradation of c-Jun in Cervical Carcinoma Cells J. Biol. Chem., October 29, 2004; 279(44): 45408 - 45416. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Prakash, C. Liu, K.-Q. Hu, N. I. Krinsky, R. M. Russell, and X.-D. Wang {beta}-Carotene and {beta}-Apo-14'-Carotenoic Acid Prevent the Reduction of Retinoic Acid Receptor {beta} in Benzo[a]pyrene-Treated Normal Human Bronchial Epithelial Cells J. Nutr., March 1, 2004; 134(3): 667 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, M. Z. Fang, J. Liao, G.-Y. Yang, Y. Nie, Y. Song, C. So, X. Xu, L.-D. Wang, and C. S. Yang Hypermethylation-Associated Inactivation of Retinoic Acid Receptor {beta} in Human Esophageal Squamous Cell Carcinoma Clin. Cancer Res., November 1, 2003; 9(14): 5257 - 5263. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. James, F. Lin, S. K. Kolluri, M. I. Dawson, and X.-k. Zhang Regulation of Retinoic Acid Receptor {beta} Expression by Peroxisome Proliferator-activated Receptor {gamma} Ligands in Cancer Cells Cancer Res., July 1, 2003; 63(13): 3531 - 3538. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhuang, T. N. Faria, P. Chambon, and L. J. Gudas Identification and Characterization of Retinoic Acid Receptor {beta}2 Target Genes in F9 Teratocarcinoma Cells Mol. Cancer Res., June 1, 2003; 1(8): 619 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prinetti, L. Basso, V. Appierto, M. G. Villani, M. Valsecchi, N. Loberto, S. Prioni, V. Chigorno, E. Cavadini, F. Formelli, et al. Altered Sphingolipid Metabolism in N-(4-Hydroxyphenyl)- retinamide-resistant A2780 Human Ovarian Carcinoma Cells J. Biol. Chem., February 14, 2003; 278(8): 5574 - 5583. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Chen, K. M. Sommer, and K. Swisshelm Downstream Codons in the Retinoic Acid Receptor beta -2 and beta -4 mRNAs Initiate Translation of a Protein Isoform That Disrupts Retinoid-activated Transcription J. Biol. Chem., September 13, 2002; 277(38): 35411 - 35421. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Singletary, E. N. Atkinson, A. Hoque, N. Sneige, A. A. Sahin, H. A. Fritsche Jr., R. Lotan, T. Lu, W. N. Hittelman, T. B. Bevers, et al. Phase II Clinical Trial of N-(4-Hydroxyphenyl)retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia Clin. Cancer Res., September 1, 2002; 8(9): 2835 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. McGregor, A. Muntoni, J. Fleming, J. Brown, D. H. Felix, D. G. MacDonald, E. K. Parkinson, and P. R. Harrison Molecular Changes Associated with Oral Dysplasia Progression and Acquisition of Immortality: Potential for Its Reversal by 5-Azacytidine Cancer Res., August 15, 2002; 62(16): 4757 - 4766. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sirchia, M. Ren, R. Pili, E. Sironi, G. Somenzi, R. Ghidoni, S. Toma, G. Nicolo, and N. Sacchi Endogenous Reactivation of the RAR{beta}2 Tumor Suppressor Gene Epigenetically Silenced in Breast Cancer Cancer Res., May 1, 2002; 62(9): 2455 - 2461. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Rexer, W. Li Zheng, and D. E. Ong Retinoic Acid Biosynthesis by Normal Human Breast Epithelium Is via Aldehyde Dehydrogenase 6, Absent in MCF-7 Cells Cancer Res., October 1, 2001; 61(19): 7065 - 7070. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Clifford, A. L. Sabichi, C. Zou, X. Yang, V. E. Steele, G. J. Kelloff, R. Lotan, and S. M. Lippman Effects of Novel Phenylretinamides on Cell Growth and Apoptosis in Bladder Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 391 - 395. [Abstract] [Full Text] |
||||
![]() |
X. Guo, D. M Nanus, A. Ruiz, R. R Rando, D. Bok, and L. J Gudas Reduced Levels of Retinyl Esters and Vitamin A in Human Renal Cancers Cancer Res., March 1, 2001; 61(6): 2774 - 2781. [Abstract] [Full Text] |
||||
![]() |
H. Wan, W. K. Hong, and R. Lotan Increased Retinoic Acid Responsiveness in Lung Carcinoma Cells that Are Nonresponsive Despite the Presence of Endogenous Retinoic Acid Receptor (RAR) {beta} by Expression of Exogenous Retinoid Receptors Retinoid X Receptor {{alpha}}, RAR{{alpha}}, and RAR{{gamma}} Cancer Res., January 1, 2001; 61(2): 556 - 564. [Abstract] [Full Text] |
||||
![]() |
Q. Yang, I. Mori, L. Shan, M. Nakamura, Y. Nakamura, H. Utsunomiya, G. Yoshimura, T. Suzuma, T. Tamaki, T. Umemura, et al. Biallelic Inactivation of Retinoic Acid Receptor {beta}2 Gene by Epigenetic Change in Breast Cancer Am. J. Pathol., January 1, 2001; 158(1): 299 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Guo, A. Ruiz, R. R. Rando, D. Bok, and L. J. Gudas Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin:retinol acyltransferase in carcinoma lines Carcinogenesis, November 1, 2000; 21(11): 1925 - 1933. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Schneider, M. Offterdinger, H. Huber, and T. W. Grunt Activation of Retinoic Acid Receptor {{alpha}} Is Sufficient for Full Induction of Retinoid Responses in SK-BR-3 and T47D Human Breast Cancer Cells Cancer Res., October 1, 2000; 60(19): 5479 - 5487. [Abstract] [Full Text] |
||||
![]() |
A. K. Virmani, A. Rathi, S. Zochbauer-Muller, N. Sacchi, Y. Fukuyama, D. Bryant, A. Maitra, S. Heda, K. M. Fong, F. Thunnissen, et al. Promoter Methylation and Silencing of the Retinoic Acid Receptor-{beta} Gene in Lung Carcinomas J Natl Cancer Inst, August 16, 2000; 92(16): 1303 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lin, D. Xiao, S. K. Kolluri, and X.-k. Zhang Unique Anti-Activator Protein-1 Activity of Retinoic Acid Receptor {beta} Cancer Res., June 1, 2000; 60(12): 3271 - 3280. [Abstract] [Full Text] |
||||
![]() |
M. Widschwendter, J. Berger, M. Hermann, H. M. Muller, A. Amberger, M. Zeschnigk, A. Widschwendter, B. Abendstein, A. G. Zeimet, G. Daxenbichler, et al. Methylation and Silencing of the Retinoic Acid Receptor-{beta}2 Gene in Breast Cancer J Natl Cancer Inst, May 17, 2000; 92(10): 826 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-N. Wei, X. Hu, and C. Chinpaisal Constitutive Activation of Retinoic Acid Receptor beta 2 Promoter by Orphan Nuclear Receptor TR2 J. Biol. Chem., April 14, 2000; 275(16): 11907 - 11914. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lin, G.-q. Chen, D. Xiao, S. K. Kolluri, X. Cao, H. Su, and X.-k. Zhang Orphan Receptor COUP-TF Is Required for Induction of Retinoic Acid Receptor beta , Growth Inhibition, and Apoptosis by Retinoic Acid in Cancer Cells Mol. Cell. Biol., February 1, 2000; 20(3): 957 - 970. [Abstract] [Full Text] |
||||
![]() |
T. N. Faria, C. Mendelsohn, P. Chambon, and L. J. Gudas The Targeted Disruption of Both Alleles of RARbeta 2 in F9 Cells Results in the Loss of Retinoic Acid-associated Growth Arrest J. Biol. Chem., September 17, 1999; 274(38): 26783 - 26788. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Sommer, L. I. Chen, P. M. Treuting, L. T. Smith, and K. Swisshelm Elevated retinoic acid receptor beta 4 protein in human breast tumor cells with nuclear and cytoplasmic localization PNAS, July 20, 1999; 96(15): 8651 - 8656. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Berg, D. M. Nanus, A. Leung, K. T. Brown, B. Hutchinson, M. Mazumdar, X.-C. Xu, R. Lotan, V. E. Reuter, and R. J. Motzer Up-Regulation of Retinoic Acid Receptor {beta} Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-{{alpha}}-2a Clin. Cancer Res., July 1, 1999; 5(7): 1671 - 1675. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Srivastava, A. R. Srivastava, Y. S. Cho-Chung, and D. L. Longo Synergistic Effects of Retinoic Acid and 8-Chloro-Adenosine 3',5'-Cyclic Monophosphate on the Regulation of Retinoic Acid Receptor {beta} and Apoptosis: Involvement of Mitochondria Clin. Cancer Res., July 1, 1999; 5(7): 1892 - 1904. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shang, C. R. Baumrucker, and M. H. Green Signal Relay by Retinoic Acid Receptors alpha and beta in the Retinoic Acid-induced Expression of Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells J. Biol. Chem., June 18, 1999; 274(25): 18005 - 18010. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-C. Xu, X. Liu, E. Tahara, S. M. Lippman, and R. Lotan Expression and Up-Regulation of Retinoic Acid Receptor-{beta} Is Associated with Retinoid Sensitivity and Colony Formation in Esophageal Cancer Cell Lines Cancer Res., May 1, 1999; 59(10): 2477 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-Y. Sun, P. Yue, and R. Lotan Induction of Apoptosis by N-(4-Hydroxyphenyl)retinamide and Its Association with Reactive Oxygen Species, Nuclear Retinoic Acid Receptors, and Apoptosis-Related Genes in Human Prostate Carcinoma Cells Mol. Pharmacol., March 1, 1999; 55(3): 403 - 410. [Abstract] [Full Text] |
||||
![]() |
J. L. Clifford, D. G. Menter, M. Wang, R. Lotan, and S. M. Lippman Retinoid Receptor-dependent and -independent Effects of N-(4-Hydroxyphenyl)retinamide in F9 Embryonal Carcinoma Cells Cancer Res., January 1, 1999; 59(1): 14 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Seewaldt, E. C. Dietze, B. S. Johnson, S. J. Collins, and M. B. Parker Retinoic Acid-mediated G1-S-Phase Arrest of Normal Human Mammary Epithelial Cells Is Independent of the Level of p53 Protein Expression Cell Growth Differ., January 1, 1999; 10(1): 49 - 59. [Abstract] [Full Text] |
||||
![]() |
G. E. Folkers, B. van der Burg, and P. T. van der Saag Promoter Architecture, Cofactors, and Orphan Receptors Contribute to Cell-specific Activation of the Retinoic Acid Receptor beta 2 Promoter J. Biol. Chem., November 27, 1998; 273(48): 32200 - 32212. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ferrari, M. Pfahl, and G. Levi Retinoic Acid Receptor gamma 1 (RARgamma 1) Levels Control RARbeta 2 Expression in SK-N-BE2(c) Neuroblastoma Cells and Regulate a Differentiation-Apoptosis Switch Mol. Cell. Biol., November 1, 1998; 18(11): 6482 - 6492. [Abstract] [Full Text] |
||||
![]() |
N. Moghal and B. G. Neel Integration of Growth Factor, Extracellular Matrix, and Retinoid Signals during Bronchial Epithelial Cell Differentiation Mol. Cell. Biol., November 1, 1998; 18(11): 6666 - 6678. [Abstract] [Full Text] |
||||
![]() |
M. Zhang, D. Magit, and R. Sager Expression of maspin in prostate cells is regulated by a positive Ets element and a negative hormonal responsive element site recognized by androgen receptor PNAS, May 27, 1997; 94(11): 5673 - 5678. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lotan, X.-C. Xu, S. M. Lippman, J. Y. Ro, J. S. Lee, J. J. Lee, and W. K. Hong Suppression of Retinoic Acid Receptor-{beta} in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin N. Engl. J. Med., May 25, 1995; 332(21): 1405 - 1411. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |